Pradaxa May Have Been Responsible For Man’s Wrongful Death

Southfield, MI (Law Firm Newswire) October 2, 2013 – Pradaxa is suspected of causing strokes, brain hemorrhages, heart attacks, gastrointestinal bleeding and death.

“Brenda Medley filed a wrongful death lawsuit against Boehringer Ingelheim alleging their anti-coagulant, Pradaxa, contributed to, or caused, her husband’s death. She is asking the court for compensatory and punitive damages, pain and suffering and medical costs,” explained Daren Monroe, of Litigation Funding Corporation, Michigan.

Howard Medley was given Pradaxa in 2011 for atrial fibrillation. In 2012, he was rushed to hospital for excessive blood loss, supposedly linked to the drug. He received a blood transfusion. He continued to bleed internally and died. The lawsuit suggests Mr. Medley died as a result of the profuse internal bleeding, caused by Pradaxa and that the drug maker was negligent in not warning medical professionals and patients that taking the drug could result in uncontrollable bleeding.
“This drug was marketed as a safe alternative to warfarin, in that it did not need continual dose adjustments and did not require constant monitoring. What they apparently did not say is there is no remedy for uncontrolled bleeding, as there is for warfarin,” Monroe outlined. Vitamin K will stop bleeding for those on warfarin.

This is not the first lawsuit of its kind filed against the drug company. In fact, there are over 1,000 that are pending being consolidated into a multidistrict litigation. There are over 542 cases in which death was the outcome of using Pradaxa. In those cases, many plaintiffs cite stroke, liver failure, hemorrhage and acute renal failure in their evidence. “Trials are expected to begin in 2014,” said Monroe.

Plaintiffs dealing with medical situations such as this usually have extremely large medical bills and no way to pay them. The best solution is to seek litigation funding and apply for a lawsuit cash advance. “Pre-settlement funding may be arranged and sent to a plaintiff, once approved, within 24-48 hours of their application. It’s a fast process and one that has helped many plaintiffs through some tough financial times, while waiting for a case resolution,” Monroe pointed out.

Learn more at http://www.litigationfundingcorp.com